Taho Pharmaceuticals Ltd. (TPE:6467)
204.00
-20.50 (-9.13%)
At close: Nov 19, 2026
| Market Cap | 10.69B +21.3% |
| Revenue (ttm) | 6.26M -22.7% |
| Net Income | -227.32M |
| EPS | -4.36 |
| Shares Out | 52.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,228,138 |
| Open | 224.50 |
| Previous Close | 224.50 |
| Day's Range | 202.50 - 224.50 |
| 52-Week Range | 100.50 - 302.00 |
| Beta | -0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 26, 2027 |